The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Thick perirenal fat predicts the growth pattern of renal cell carcinoma.
 
Eiji Kashiwagi
No Relationships to Disclose
 
Kenjiro Imada
No Relationships to Disclose
 
Masaki Shiota
Speakers' Bureau - Astellas Oncology; Bayer; Janssen; Sanofi
 
Ario Takeuchi
Speakers' Bureau - Astellas Oncology; AstraZeneca; Chugai Pharma
 
Junichi Inokuchi
Speakers' Bureau - Astellas Oncology; Daiichi Sankyo; Olympus; Takeda
 
Katsunori Tatsugami
Speakers' Bureau - Asterias Biotherapeutics; AstraZeneca Japan; Bayer; Novartis; Novartis; Ono Pharmaceutical; Pfizer
 
Masatoshi Eto
Consulting or Advisory Role - AstraZeneca Japan; Bristol-Myers Squibb; Chugai Pharma; Eisai; Novartis; Ono Pharmaceutical; Pfizer
Speakers' Bureau - Astellas Pharma; AstraZeneca Japan; Bayer; Bristol-Myers Squibb; Janssen; Kissei Pharmaceutical; MSD; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Sanofi; Taiho Pharmaceutical; Takeda
Research Funding - ASKA Pharmaceutical (Inst); Astellas Pharma (Inst); Bayer (Inst); Chugai Pharma (Inst); Kissei Pharmaceutical (Inst); Lilly (Inst); novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)